EUVIMEDEUVIMED entdecken
Crossref

Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy

Taha Koray Sahin, Yakup Ozbay, Ahmet Yasir Altunbulak, Halil Ibrahim Altunbulak, Mehmet Ruhi Onur, Furkan Ceylan, Deniz Can Guven, Suayib Yalcin, Omer Dizdar

International Journal of Clinical Oncology · 2024-06 · 29 (6) · 822-831

DOI: 10.1007/s10147-024-02512-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Oncology, online erschienen am 02.04.2024. Verfasst von Taha Koray Sahin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Sihhiye, 06100, Ankara, Turkey. takorsah@gmail.com. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Sarcopenia, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsSarcopeniaCarcinoma, Pancreatic DuctalHumansMaleFemaleMiddle AgedAgedPrognosisMuscle, SkeletalTomography, X-Ray ComputedRetrospective StudiesSerum AlbuminAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

AlbuminAlbumin-myosteatosis gaugeInflammationMyosteatosisPancreatic cancer

Substanzen

Serum Albumin

Autor:innen und Institutionen

  • Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Sihhiye, 06100, Ankara, Turkey. takorsah@gmail.com.
  • Department of Radiology, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
  • Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey.
  • Department of Medical Oncology, Faculty of Medicine, Hacettepe University, Sihhiye, 06100, Ankara, Turkey.

Zitieren

APA

Sahin, T. K., Ozbay, Y., Altunbulak, A. Y., Altunbulak, H. I., Onur, M. R., Ceylan, F., Guven, D. C., Yalcin, S., & Dizdar, O. (2024). Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy. International Journal of Clinical Oncology, 29(6), 822-831. https://doi.org/10.1007/s10147-024-02512-4

Vancouver

Sahin TK, Ozbay Y, Altunbulak AY, Altunbulak HI, Onur MR, Ceylan F, et al. Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy. International Journal of Clinical Oncology. 2024;29(6):822-831. doi:10.1007/s10147-024-02512-4

BibTeX
@article{Sahin2024,
  author = {Sahin, Taha Koray and Ozbay, Yakup and Altunbulak, Ahmet Yasir and Altunbulak, Halil Ibrahim and Onur, Mehmet Ruhi and Ceylan, Furkan and Guven, Deniz Can and Yalcin, Suayib and Dizdar, Omer},
  title = {Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy},
  journal = {International Journal of Clinical Oncology},
  year = {2024},
  volume = {29},
  number = {6},
  pages = {822--831},
  doi = {10.1007/s10147-024-02512-4}
}
Kostenlos starten →